Clinical Trials Directory

Trials / Completed

CompletedNCT06668883

Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study

Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study (Acronym: AeroCAP)

Status
Completed
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
Avelo AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will assess the performance of two novel breath collection devices and their subsequent detection of respiratory pathogens compared to sputum samples in patients with lower respiratory tract infections.

Conditions

Interventions

TypeNameDescription
PROCEDURESputum collection for molecular analysisSputum collection to be used with syndromic multiplex PCR testing
DEVICEBreath and cough collection for molecular analysisBreath and cough collection with two proprietary devices to be used with syndromic multiplex PCR testing

Timeline

Start date
2024-11-13
Primary completion
2025-05-21
Completion
2025-05-21
First posted
2024-11-01
Last updated
2025-08-08

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT06668883. Inclusion in this directory is not an endorsement.

Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and A (NCT06668883) · Clinical Trials Directory